Metabolic activity of primary tumour on PET/CT has a relationship with survival in stages I-III small-cell lung carcinoma.
Özer ÖzdemirÖzgür BatumSinem ErminNimet AkselBerna KömürcüoğluAydan MertoğluSami DenizGünseli BalcıHakan KoparalEngin ÖzbilekUfuk YılmazPublished in: The clinical respiratory journal (2020)
Pretreatment SUVmax -PT (median cut-off 11.6) may have a prognostic value of OS and PFS in patients with TNM staged I-III SCLC.